Article
Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
The Journal of antimicrobial chemotherapy - 1 Jan 2004
de la Rosa Rafael, Ruíz-Mateos Ezequiel, Rubio Amalia, Abad María Antonia, Vallejo Alejandro, Rivero Laura, Genebat Miguel, Sánchez-Quijano Armando, Lissen Eduardo, Leal Manuel
Abstract excerpt
OBJECTIVE: To assess the durability of the undetectability of HIV plasma viraemia (pV) and to determine the factors associated with virological rebound (VR) in HIV-infected adults on protease inhibitor (PI)-sparing highly active antiretroviral therapy (HAART). The development of resistance mutations during virologically successful therapy and VR was also analysed. MATERIALS AND METHODS: One hundred and twenty-six...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.